Skip to content
Acting Auditions – Lifestyle
Author:
ABBOTT LABORATORIES
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
May 26, 2026
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
April 28, 2026
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
April 25, 2026
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
April 17, 2026
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
April 16, 2026
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
April 9, 2026
Abbott expands access to Precision Oncology portfolio through integration with Flatiron’s OncoEMR® platform
March 30, 2026
Abbott hosts conference call for first-quarter earnings
March 26, 2026
John Stamos and Jodie Sweetin reunite for “The (Second) Talk” with Cologuard® tests, encouraging colon cancer screening
March 24, 2026
Abbott completes acquisition of Exact Sciences
March 23, 2026
1
2
Next Page
→